Skip to main content

Table 1 The demographics of participants

From: The experience of patients with hematological malignancy in their terminal stage: a phenomenological study from Jordan’s perspective

Name/

pseudonym

Gender

Age (year)

HMs subtype

Duration since diagnosis (months)

Length of the interview (minutes)

P1

Female

49

Lymphoma

14

60

P2

Female

56

Lymphoma

18

70

P3

Female

49

Leukemia

10

90

P4

Male

61

Lymphoma

42

70

P5

Female

50

Lymphoma

60

50

P6

Female

54

Lymphoma

84

70

P7

Female

58

Lymphoma

24

80

P8

Male

53

Leukemia

36

100

P9

Male

55

Lymphoma

30

70

P10

Male

65

Lymphoma

16

90